Inhibikase Therapeutics Competitors and Similar CompaniesClear all

Inhibikase Therapeutics's competitors and similar companies include Genentech, Mankind Pharma and UCB.

	Inhibikase Therapeutics Inhibikase Therapeutics is a pharmaceutical company that develops neurodegenerative disease treatments.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 2008	Founding Date 1976	Founding Date 1995	Founding Date 1928
Type	Type Public	Type Subsidiary	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Atlanta, US HQ Lexington, US	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations New Delhi, IN HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 1588% increase	Employees 18,077	Employees 16,2532% increase	Employees 9,052
Valuation ($)	Valuation ($) 173.6 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 34.3 b
Financial
Net income	Net income ($48.3m) (FY, 2025)	Net income N/A	Net income N/A	Net income €1.6b (FY, 2025)
Operating ⚠
Phase I Trials Products	Phase I Trials Products 1 (Q3, 2020)	Phase I Trials Products 28 (Jul, 2025)	Phase I Trials Products N/A	Phase I Trials Products N/A